LifePoint Health, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2018. For the quarter, the company's revenues were $1,569.8 million compared to $1,594.8 million a year ago, an increase of 0.6%. Income before income taxes was $71.8 million compared to $70.4 million a year ago. Net income attributable to the company was $52.4 million compared to $42.5 million a year ago. Diluted earnings per share attributable to the company's stockholders were $1.33 compared to dilute $1.03 a year ago. Net cash provided by operating activities was $134.8 million compared to $110.6 million a year ago. Purchases of property and equipment were $81.4 million compared to $89.2 million a year ago. Adjusted net income was $52.4 million compared to $43.2 million a year ago. Adjusted diluted earnings per share attributable to the company's stockholders were $1.27 against $0.96 a year ago. Adjusted EBITDA was $187.0 million compared to $192.2 million a year ago. This decrease in adjusted EBITDA was primarily the result of the recognition of $4.3 million less in Medicare and Medicaid electronic health record (“EHR”) incentive income during the second quarter of 2018 compared to the same period last year. The Company's EHR incentive payments under this program substantially concluded in 2017.

For the six months, the company's revenues were $3,172.6 million compared to $3,225.0 million a year ago. Income before income taxes was $69.0 million compared to $166.4 million a year ago. Net income attributable to the company was $43.6 million compared to $102.4 million a year ago. Diluted earnings per share attributable to the company's stockholders were $1.10 compared to dilute $2.49 a year ago. Net cash provided by operating activities was $235.4 million compared to $202.3 million a year ago. Purchases of property and equipment were $137.6 million compared to $157.7 million a year ago. Adjusted net income was $104.1 million compared to $91.0 million a year ago. Adjusted diluted earnings per share attributable to the company's stockholders were $2.48 against $2.03 a year ago. Adjusted EBITDA was $375.5 million compared to $387.8 million a year ago. This decrease in adjusted EBITDA was primarily the result of the recognition of $7.5 million less in Medicare and Medicaid EHR incentive income during the six months ended June 30, 2018, compared to the same period last year.

The company provided revised guidance for 2018. For the year the company expects revenues of $6.25 billion to $6.32 billion, same-hospital revenue growth of 0.5% - 1.6%, adjusted EBITDA of $730 million to $760 million, adjusted diluted EPS of $4.50 to $4.93 and capital expenditures of $475 million to $500 million.